Expert Rev Proteomics. 2024 Aug 21. doi: 10.1080/14789450.2024.2395398. Online ahead of print.
ABSTRACT
INTRODUCTION: Oral squamous cell carcinoma (OSCC) represents the most prevalent form of oral cancer. Potentially malignant disorders of oral mucosa exhibit an elevated propensity for malignant progression. A substantial proportion of cases are discerned during advanced stages, significantly impacting overall survival. This investigation aims to ascertain salivary metabolites with potential utility in the early detection of OSCC.
METHODS: A search encompassing PubMed, EMBASE, Scopus, Ovid, Science Direct, and Web of Science databases was conducted to identify eligible articles. The search strategy employed precise terms. The quality assessment of the included studies was executed using the QUADAS 2 ROB tool. This was registered with PROSPERO CRD42021278217.
RESULTS: Upon removing duplicate articles and publications that didn’t satisfy the inclusion criteria, seven articles were included in the current study. The Random Effects Maximum Likelihood (REML) model adopted for quantitative synthesis identified N-acetyl glucosamine as the sole metabolite in two studies included in this meta-analysis. The pathways significantly influenced by these identified metabolites were delineated.
CONCLUSION: This study highlights N-acetyl glucosamine as a distinctive metabolite with the potential to serve as an early diagnostic marker for OSCC. Nevertheless, further research is warranted to validate its clinical utility.
PMID:39166387 | DOI:10.1080/14789450.2024.2395398
